Prevention effect of transcutaneous electrical acupoint stimulation for chemotherapy-related myelosuppression in non-small cell lung cancer.
10.13703/j.0255-2930.20190626-k0002
- Author:
Fang-Chao ZHAO
1
;
Cheng-Yuan YE
2
;
Wei-Jian WANG
3
;
Jian-Ming LIU
1
Author Information
1. Affiliated Tangshan People's Hospital of North China University of Science and Technology Department of Thoracic Surgery, Tangshan 063000, Hebei Province, China.
2. Affiliated Tangshan People's Hospital of North China University of Science and Technology Department of Cancer Comprehensive Therapy, Tangshan 063000, Hebei Province, China.
3. Department of Orthopedics, Tangshan 063000, Hebei Province, China.
- Publication Type:Journal Article
- Keywords:
chemotherapy;
myelosuppression;
non-small cell lung cancer;
transcutaneous electrical acupoint stimulation (TEAS)
- MeSH:
Acupuncture Points;
Bone Marrow;
drug effects;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
therapy;
Cisplatin;
therapeutic use;
Deoxycytidine;
analogs & derivatives;
therapeutic use;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Lung Neoplasms;
drug therapy;
therapy;
Transcutaneous Electric Nerve Stimulation
- From:
Chinese Acupuncture & Moxibustion
2020;40(6):596-600
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the prevention effect of transcutaneous electrical acupoint stimulation (TEAS) for chemotherapy-related myelosuppression in non-small cell lung cancer.
METHODS:A total of 102 patients with non-small cell lung cancer who received initial chemotherapy were randomly divided into a conventional group, a medication group and a TEAS group, 34 cases in each one. The conventional group was treated with chemotherapy of gemcitabine combined with cisplatin and given routine care. On the basis of conventional group's treatment, the medication group was given tablets before chemotherapy, 2-3 tablets each time, 3 times a day. In the TEAS group, on the basis of conventional group's treatment, TEAS was applied at Dazhui (GV 14), Geshu (BL 17), Hegu (LI 4), Zusanli (ST 36) and Sanyinjiao (SP 6) on day 1, 2, 3, 5, 8, 14, 21 and 28 of chemotherapy. The treatment was given 30 min each time and once a day. In the three groups, the treatment for 28 days was as one course and one course of treatment was required. The changes of leukocytes, platelets, erythrocyte, hemoglobin indexes in patients of the three groups were observed one day before chemotherapy and on day 5, 8, 11, 14, 21 and 28 of chemotherapy. The comfort situation of patients was observed one day before chemotherapy and on the 5th, 11th and 21st day of chemotherapy.
RESULTS:Compared with before chemotherapy, the leukocyte counts of three groups were decreased at various time points after chemotherapy (<0.05). Compared with the conventional group, the leukocyte counts were higher on day 8 and 14 in the TEAS group and on day 14 in the medication group (<0.05). Compared with before chemotherapy, the platelet count decreased on the day 5, 8, 11 and 14 of chemotherapy in the conventional group (<0.05), and the platelet counts all decreased at each time point after chemotherapy in the medication group (<0.05). The platelet counts of the TEAS group on day 5, 8, 11 and 14 of chemotherapy were higher than those of the conventional group (<0.05), and the platelet counts of the TEAS group on day 5, 8, 11 and 21 of chemotherapy were higher than those of the medication group (<0.05). Compared with the conventional group, the comfort situation scores of the TEAS group were higher on the 5th and 11th days of chemotherapy (<0.05).
CONCLUSION:Transcutaneous electrical acupoint stimulation can prevent chemotherapy-induced myelosuppression (leukocyte, platelets) in patients with non-small cell lung cancer and improve patient comfort situation.
